Position in CSBR
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$264,109
-$54,758 QoQ
Shares Held
45,932
-0.5% QoQ
Ownership
0.331%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CSBR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORTHERN TRUST CORP holds $6,610,487,463 across 418 Biotechnology names. CSBR ranks #306 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,564,264 | $1,145,046,441 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
941,941 | $727,781,290 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
858,120 | $283,926,160 | |
| 4 | INSM |
INSMED Inc
|
1,294,000 | $211,594,876 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,808,735 | $182,705,014 | |
| 6 | INCY |
Incyte Corp
|
1,849,726 | $174,096,208 | |
| 7 | MRNA |
Moderna, Inc.
|
2,952,041 | $149,963,680 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,403,642 | $104,234,453 |
All Filings in CSBR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $264,109 | 45,932 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $318,867 | 46,146 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $300,892 | 46,434 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $396,225 | 53,762 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $468,389 | 53,962 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $462,728 | 53,994 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $200,014 | 41,071 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $209,193 | 40,463 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $209,175 | 42,689 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $252,432 | 44,917 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $192,633 | 31,020 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $199,674 | 31,297 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $115,719 | 28,786 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $126,789 | 28,113 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $210,502 | 28,067 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $218,440 | 27,305 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $223,029 | 27,433 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $229,699 | 27,476 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $284,532 | 27,868 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $284,950 | 27,719 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,005,055 | 88,943 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,157,345 | 107,261 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $1,032,909 | 111,666 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $547,576 | 57,278 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $202,367 | 27,347 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||